Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
By N. Tang, Dengju Li, Xiong Wang, Ziyong Sun. Journal of Thrombosis and Haemostasis, 2020
5,439 citations recorded by the source corpus.
In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronavirus pneumonia (NCP) cases were a concern.
Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/37afffff1ca9c3f02fd96c839818ccdf2b80a087
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Epidemiology
- C. Richard
- Harlan M. Krumholz
- David Attwell
- M. Trauner
- Djillali Annane
- X. Monnet
- T. Guzik
- Rhian M. Touyz
In Infectious Diseases
Citations in the corpus
- COVID-19 cytokine storm: the interplay between inflammation and coagulation (2020, background): “1, 6 The finding of increased d-dimer levels in patients with COVID-19 has prompted questions regarding coexistence of venous thromboembolism exacerbating ventilation-perfusion mismatch, and some studies have shown that pulmonary emboli are prevalent.”
- Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19 (2020, background): “Time from symptom onset to blood sample, d — 6 (1-12)† 12 (8-17)”
- Cardiovascular complications in COVID-19 (2020, neutral): “Systemic inflammation, abnormal coagulation status, multiorgan dysfunction, and critical illness are all potential contributing factors to the increased risk of VTE [7, 8, [35] [36] [37] [38] .”
- Neutrophil extracellular traps in COVID-19. (2020, background): “Hyperactivity of the coagulation system is a common finding of severe COVID-19 24 .”
- COVID-19 update: Covid-19-associated coagulopathy (2020, background): “reported on abnormal coagulation parameters and poor prognosis in 183 consecutive patients with Covid-19 pneumonia [2].”
- SARS-CoV-2 and viral sepsis: observations and hypotheses (2020, background): “Studies have revealed that 71·4% of non-survivors of COVID-19 matched the grade of overt disseminated intravascular coagulation (≥5 points according to the International Society on Thrombosis and Haemostasis criteria) 27 and showed abnormal coagulation results during later stages of the disease; par”
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases (2020, neutral): “Organ dysfunction, particularly progressive respiratory failure and a generalized coagulopathy, are associated with the highest mortality.(1,4,5) It was soon recognized that SARS-CoV-2 is but one of a large pool of prepandemic SARS-like bat coronaviruses which replicate in primary human airway epith”